FOXJ2 directly augments SLAMF8/TREM1 signaling, consequently accelerating APS pathogenesis by repressing autophagy and promoting the release of proinflammatory and prothrombotic cytokines. Here, FOXJ2 is linked to autoimmune polyendocrinopathy.